

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | thrombin receptor signaling pathway (GO:0070493) | 7.90479980 |
| 2 | protein neddylation (GO:0045116) | 7.79455767 |
| 3 | neutrophil activation involved in immune response (GO:0002283) | 7.53670639 |
| 4 | regulation of platelet aggregation (GO:0090330) | 6.26787144 |
| 5 | blood coagulation, intrinsic pathway (GO:0007597) | 6.15747425 |
| 6 | regulation of platelet activation (GO:0010543) | 5.85980690 |
| 7 | adenosine receptor signaling pathway (GO:0001973) | 5.57108650 |
| 8 | platelet aggregation (GO:0070527) | 5.54676607 |
| 9 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 5.31760348 |
| 10 | leukocyte migration involved in inflammatory response (GO:0002523) | 5.25881151 |
| 11 | negative regulation of thymocyte apoptotic process (GO:0070244) | 5.20057077 |
| 12 | positive regulation of endothelial cell differentiation (GO:0045603) | 5.18979920 |
| 13 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.17644122 |
| 14 | regulation of integrin-mediated signaling pathway (GO:2001044) | 5.14184139 |
| 15 | negative regulation of norepinephrine secretion (GO:0010700) | 5.08522805 |
| 16 | negative regulation of platelet activation (GO:0010544) | 4.95864567 |
| 17 | lipoxygenase pathway (GO:0019372) | 4.72772845 |
| 18 | positive regulation of mast cell activation (GO:0033005) | 4.71839975 |
| 19 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 4.59431206 |
| 20 | angiogenesis involved in wound healing (GO:0060055) | 4.58499117 |
| 21 | negative regulation of heart rate (GO:0010459) | 4.56679699 |
| 22 | neutrophil activation (GO:0042119) | 4.51423513 |
| 23 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 4.49365856 |
| 24 | platelet degranulation (GO:0002576) | 4.28205721 |
| 25 | regulation of lipoprotein metabolic process (GO:0050746) | 4.19797164 |
| 26 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 4.14294871 |
| 27 | regulation of integrin activation (GO:0033623) | 4.12480975 |
| 28 | positive regulation of cAMP-mediated signaling (GO:0043950) | 4.11860883 |
| 29 | polyamine biosynthetic process (GO:0006596) | 4.10729698 |
| 30 | low-density lipoprotein particle remodeling (GO:0034374) | 4.07391463 |
| 31 | positive regulation of macrophage differentiation (GO:0045651) | 4.02117794 |
| 32 | granulocyte activation (GO:0036230) | 3.96613529 |
| 33 | megakaryocyte development (GO:0035855) | 3.93218711 |
| 34 | negative regulation of protein localization to cell surface (GO:2000009) | 3.92903498 |
| 35 | homotypic cell-cell adhesion (GO:0034109) | 3.88819231 |
| 36 | platelet activation (GO:0030168) | 3.88417807 |
| 37 | regulation of homotypic cell-cell adhesion (GO:0034110) | 3.82585010 |
| 38 | negative regulation of appetite (GO:0032099) | 3.81534226 |
| 39 | negative regulation of response to food (GO:0032096) | 3.81534226 |
| 40 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 3.79142352 |
| 41 | positive regulation of Rho protein signal transduction (GO:0035025) | 3.72442780 |
| 42 | negative regulation of hematopoietic progenitor cell differentiation (GO:1901533) | 3.72374298 |
| 43 | fusion of sperm to egg plasma membrane (GO:0007342) | 3.70546128 |
| 44 | platelet formation (GO:0030220) | 3.66772223 |
| 45 | regulation of MHC class II biosynthetic process (GO:0045346) | 3.64695877 |
| 46 | positive regulation of hemostasis (GO:1900048) | 3.59897039 |
| 47 | positive regulation of blood coagulation (GO:0030194) | 3.59897039 |
| 48 | purinergic receptor signaling pathway (GO:0035587) | 3.55491900 |
| 49 | positive regulation of receptor recycling (GO:0001921) | 3.55384802 |
| 50 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.54300624 |
| 51 | positive regulation of systemic arterial blood pressure (GO:0003084) | 3.52690571 |
| 52 | regulation of endothelial cell differentiation (GO:0045601) | 3.50582447 |
| 53 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.50418363 |
| 54 | regulation of norepinephrine secretion (GO:0014061) | 3.48499803 |
| 55 | negative regulation of heart contraction (GO:0045822) | 3.45820441 |
| 56 | autophagic vacuole fusion (GO:0000046) | 3.43027768 |
| 57 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.41826898 |
| 58 | beta-amyloid metabolic process (GO:0050435) | 3.39011427 |
| 59 | negative regulation of T cell apoptotic process (GO:0070233) | 3.36285704 |
| 60 | termination of G-protein coupled receptor signaling pathway (GO:0038032) | 3.33678644 |
| 61 | negative regulation of neural precursor cell proliferation (GO:2000178) | 3.30655982 |
| 62 | termination of signal transduction (GO:0023021) | 3.29002038 |
| 63 | extracellular fibril organization (GO:0043206) | 3.24884193 |
| 64 | phagocytosis, engulfment (GO:0006911) | 3.22889784 |
| 65 | positive regulation of coagulation (GO:0050820) | 3.21154606 |
| 66 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.19415063 |
| 67 | fatty acid elongation (GO:0030497) | 3.18001019 |
| 68 | mitochondrial calcium ion transport (GO:0006851) | 3.15879432 |
| 69 | negative regulation of catecholamine secretion (GO:0033604) | 3.14023254 |
| 70 | leukocyte degranulation (GO:0043299) | 3.10393918 |
| 71 | vesicle targeting (GO:0006903) | 3.09000165 |
| 72 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.07101039 |
| 73 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.07101039 |
| 74 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 3.05735394 |
| 75 | regulation of mast cell activation (GO:0033003) | 3.05693958 |
| 76 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.04782400 |
| 77 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 3.01723960 |
| 78 | regulation of female receptivity (GO:0045924) | 2.97693661 |
| 79 | regulation of blood coagulation (GO:0030193) | 2.97650685 |
| 80 | regulation of hemostasis (GO:1900046) | 2.97650685 |
| 81 | cyclooxygenase pathway (GO:0019371) | 2.96237103 |
| 82 | high-density lipoprotein particle remodeling (GO:0034375) | 2.94590370 |
| 83 | cellular biogenic amine biosynthetic process (GO:0042401) | 2.91778859 |
| 84 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.88257200 |
| 85 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.86157947 |
| 86 | positive regulation of mast cell degranulation (GO:0043306) | 2.86157947 |
| 87 | regulation of regulatory T cell differentiation (GO:0045589) | 2.85522232 |
| 88 | regulation of receptor recycling (GO:0001919) | 2.85100915 |
| 89 | membrane invagination (GO:0010324) | 2.83938957 |
| 90 | regulation of mast cell degranulation (GO:0043304) | 2.83878150 |
| 91 | regulation of memory T cell differentiation (GO:0043380) | 2.83333800 |
| 92 | regulation of cholesterol efflux (GO:0010874) | 2.81662846 |
| 93 | reverse cholesterol transport (GO:0043691) | 2.81405613 |
| 94 | negative regulation of stress fiber assembly (GO:0051497) | 2.79740806 |
| 95 | fibril organization (GO:0097435) | 2.75677715 |
| 96 | negative regulation of focal adhesion assembly (GO:0051895) | 2.75550413 |
| 97 | negative regulation of cell junction assembly (GO:1901889) | 2.75550413 |
| 98 | negative regulation of adherens junction organization (GO:1903392) | 2.75550413 |
| 99 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.75331862 |
| 100 | positive regulation of B cell mediated immunity (GO:0002714) | 2.74251324 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 4.93457424 |
| 2 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 4.29468836 |
| 3 | SCL_19346495_ChIP-Seq_HPC-7_Human | 4.20355386 |
| 4 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.33740947 |
| 5 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 3.29636738 |
| 6 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 3.18035436 |
| 7 | GATA1_19941826_ChIP-Seq_K562_Human | 3.05193579 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.04937460 |
| 9 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.83484681 |
| 10 | GATA2_19941826_ChIP-Seq_K562_Human | 2.63211216 |
| 11 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.61206762 |
| 12 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.60197660 |
| 13 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.53032509 |
| 14 | SPI1_23127762_ChIP-Seq_K562_Human | 2.35943926 |
| 15 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.32614754 |
| 16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.32297942 |
| 17 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.31024686 |
| 18 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 2.21866087 |
| 19 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.21173063 |
| 20 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 2.18424684 |
| 21 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 2.15330409 |
| 22 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.09604936 |
| 23 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 2.07189555 |
| 24 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.97343065 |
| 25 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.95637003 |
| 26 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.93316861 |
| 27 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.88905234 |
| 28 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.87973424 |
| 29 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.87269539 |
| 30 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.86352686 |
| 31 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.84565302 |
| 32 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.83199162 |
| 33 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.80850452 |
| 34 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.71093206 |
| 35 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.68596028 |
| 36 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.66604053 |
| 37 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.66309340 |
| 38 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.63454741 |
| 39 | GATA1_22025678_ChIP-Seq_K562_Human | 1.60585219 |
| 40 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.50362503 |
| 41 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.42784181 |
| 42 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.40238863 |
| 43 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.31176504 |
| 44 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.30780370 |
| 45 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.29195408 |
| 46 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.29195408 |
| 47 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.28487106 |
| 48 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.25378240 |
| 49 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.20096027 |
| 50 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.09755569 |
| 51 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.07545482 |
| 52 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.05842645 |
| 53 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.04657440 |
| 54 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.04235765 |
| 55 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.03635000 |
| 56 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.03356156 |
| 57 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 1.02102191 |
| 58 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.01307560 |
| 59 | * SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.97636872 |
| 60 | LMO2_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.96478852 |
| 61 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95226639 |
| 62 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.93903692 |
| 63 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.93350803 |
| 64 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.89381098 |
| 65 | UTX_26944678_Chip-Seq_JUKART_Human | 0.88917488 |
| 66 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.87079734 |
| 67 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.87043488 |
| 68 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.86746870 |
| 69 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.86066843 |
| 70 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.86057936 |
| 71 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.84944910 |
| 72 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.84719805 |
| 73 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.83889583 |
| 74 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.83547736 |
| 75 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.83340513 |
| 76 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.83298074 |
| 77 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.82134025 |
| 78 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.82103051 |
| 79 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.81723137 |
| 80 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.80937810 |
| 81 | GATA3_26560356_Chip-Seq_TH2_Human | 0.79763728 |
| 82 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.78999028 |
| 83 | MYB_26560356_Chip-Seq_TH2_Human | 0.78707886 |
| 84 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.78677288 |
| 85 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.76941443 |
| 86 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.76619780 |
| 87 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.76298997 |
| 88 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.76031201 |
| 89 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.75956508 |
| 90 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.75046714 |
| 91 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.74476357 |
| 92 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.74413267 |
| 93 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.73989287 |
| 94 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.73790564 |
| 95 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.72381989 |
| 96 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.72083255 |
| 97 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.71942785 |
| 98 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.71416186 |
| 99 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.71278929 |
| 100 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.70297576 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008004_abnormal_stomach_pH | 5.60000585 |
| 2 | MP0003724_increased_susceptibility_to | 4.00234400 |
| 3 | MP0000465_gastrointestinal_hemorrhage | 3.60511203 |
| 4 | MP0004510_myositis | 3.15747595 |
| 5 | MP0005083_abnormal_biliary_tract | 2.50323647 |
| 6 | MP0003303_peritoneal_inflammation | 2.46143655 |
| 7 | MP0000343_altered_response_to | 2.35721580 |
| 8 | MP0003566_abnormal_cell_adhesion | 2.31721437 |
| 9 | MP0001835_abnormal_antigen_presentation | 2.30092472 |
| 10 | MP0004084_abnormal_cardiac_muscle | 2.18143437 |
| 11 | MP0002736_abnormal_nociception_after | 2.13997541 |
| 12 | MP0000230_abnormal_systemic_arterial | 2.08571945 |
| 13 | MP0005464_abnormal_platelet_physiology | 10.0950480 |
| 14 | MP0005671_abnormal_response_to | 1.84374692 |
| 15 | MP0003638_abnormal_response/metabolism_ | 1.76732959 |
| 16 | MP0003828_pulmonary_edema | 1.76579546 |
| 17 | MP0010155_abnormal_intestine_physiology | 1.71333064 |
| 18 | MP0008775_abnormal_heart_ventricle | 1.68300509 |
| 19 | MP0002148_abnormal_hypersensitivity_rea | 1.68202229 |
| 20 | MP0005084_abnormal_gallbladder_morpholo | 1.67532594 |
| 21 | MP0001851_eye_inflammation | 1.65229588 |
| 22 | MP0005167_abnormal_blood-brain_barrier | 1.65076166 |
| 23 | MP0005058_abnormal_lysosome_morphology | 1.61186698 |
| 24 | MP0005000_abnormal_immune_tolerance | 1.58093088 |
| 25 | MP0008872_abnormal_physiological_respon | 1.57610254 |
| 26 | MP0001879_abnormal_lymphatic_vessel | 1.57343724 |
| 27 | MP0003879_abnormal_hair_cell | 1.55608340 |
| 28 | MP0004036_abnormal_muscle_relaxation | 1.54312142 |
| 29 | MP0005410_abnormal_fertilization | 1.53135682 |
| 30 | MP0004130_abnormal_muscle_cell | 1.46229221 |
| 31 | MP0003436_decreased_susceptibility_to | 1.46027884 |
| 32 | MP0002398_abnormal_bone_marrow | 1.44611906 |
| 33 | MP0001663_abnormal_digestive_system | 1.39977988 |
| 34 | MP0000249_abnormal_blood_vessel | 1.37688162 |
| 35 | MP0002132_abnormal_respiratory_system | 1.34594029 |
| 36 | MP0001545_abnormal_hematopoietic_system | 1.34255165 |
| 37 | MP0005397_hematopoietic_system_phenotyp | 1.34255165 |
| 38 | MP0004947_skin_inflammation | 1.32493594 |
| 39 | MP0001968_abnormal_touch/_nociception | 1.32108273 |
| 40 | MP0001533_abnormal_skeleton_physiology | 1.25818890 |
| 41 | MP0009763_increased_sensitivity_to | 1.24503776 |
| 42 | MP0002723_abnormal_immune_serum | 1.22085922 |
| 43 | MP0005646_abnormal_pituitary_gland | 1.21891975 |
| 44 | MP0010329_abnormal_lipoprotein_level | 1.21366149 |
| 45 | MP0000858_altered_metastatic_potential | 1.19888885 |
| 46 | MP0002733_abnormal_thermal_nociception | 1.17057495 |
| 47 | MP0009764_decreased_sensitivity_to | 1.16535088 |
| 48 | MP0003300_gastrointestinal_ulcer | 1.14049148 |
| 49 | MP0003866_abnormal_defecation | 1.13496891 |
| 50 | MP0001800_abnormal_humoral_immune | 1.12175802 |
| 51 | MP0002452_abnormal_antigen_presenting | 1.10520207 |
| 52 | MP0008874_decreased_physiological_sensi | 1.04001716 |
| 53 | MP0002429_abnormal_blood_cell | 1.02645539 |
| 54 | MP0000689_abnormal_spleen_morphology | 1.01986000 |
| 55 | MP0002419_abnormal_innate_immunity | 0.98615939 |
| 56 | MP0002420_abnormal_adaptive_immunity | 0.98043087 |
| 57 | MP0006054_spinal_hemorrhage | 0.97273811 |
| 58 | MP0003656_abnormal_erythrocyte_physiolo | 0.97203284 |
| 59 | MP0001819_abnormal_immune_cell | 0.96538870 |
| 60 | MP0009642_abnormal_blood_homeostasis | 0.95656489 |
| 61 | MP0001790_abnormal_immune_system | 0.95533577 |
| 62 | MP0005387_immune_system_phenotype | 0.95533577 |
| 63 | MP0009765_abnormal_xenobiotic_induced | 0.95084986 |
| 64 | MP0001845_abnormal_inflammatory_respons | 0.92806475 |
| 65 | MP0002998_abnormal_bone_remodeling | 0.91757049 |
| 66 | MP0002722_abnormal_immune_system | 0.90959110 |
| 67 | MP0004215_abnormal_myocardial_fiber | 0.88747088 |
| 68 | MP0005381_digestive/alimentary_phenotyp | 0.87689762 |
| 69 | MP0005023_abnormal_wound_healing | 0.87595651 |
| 70 | MP0005025_abnormal_response_to | 0.87312580 |
| 71 | MP0000716_abnormal_immune_system | 0.86892106 |
| 72 | MP0005165_increased_susceptibility_to | 0.85736391 |
| 73 | MP0009333_abnormal_splenocyte_physiolog | 0.85069992 |
| 74 | MP0001664_abnormal_digestion | 0.83400673 |
| 75 | MP0001970_abnormal_pain_threshold | 0.83319513 |
| 76 | MP0000685_abnormal_immune_system | 0.82080406 |
| 77 | MP0001765_abnormal_ion_homeostasis | 0.81770595 |
| 78 | MP0009697_abnormal_copulation | 0.80021727 |
| 79 | MP0005666_abnormal_adipose_tissue | 0.79970419 |
| 80 | MP0006276_abnormal_autonomic_nervous | 0.79445477 |
| 81 | MP0000015_abnormal_ear_pigmentation | 0.79368550 |
| 82 | MP0002972_abnormal_cardiac_muscle | 0.78066747 |
| 83 | MP0004484_altered_response_of | 0.76964031 |
| 84 | MP0001544_abnormal_cardiovascular_syste | 0.75557986 |
| 85 | MP0005385_cardiovascular_system_phenoty | 0.75557986 |
| 86 | MP0004883_abnormal_blood_vessel | 0.75265840 |
| 87 | MP0003075_altered_response_to | 0.74635183 |
| 88 | MP0005409_darkened_coat_color | 0.71244274 |
| 89 | MP0005535_abnormal_body_temperature | 0.70951689 |
| 90 | MP0003453_abnormal_keratinocyte_physiol | 0.70938425 |
| 91 | MP0008260_abnormal_autophagy | 0.70177234 |
| 92 | MP0002118_abnormal_lipid_homeostasis | 0.69932943 |
| 93 | MP0002128_abnormal_blood_circulation | 0.69166303 |
| 94 | MP0005501_abnormal_skin_physiology | 0.67780677 |
| 95 | MP0000490_abnormal_crypts_of | 0.66587803 |
| 96 | MP0006138_congestive_heart_failure | 0.64081221 |
| 97 | MP0005620_abnormal_muscle_contractility | 0.60920911 |
| 98 | MP0003183_abnormal_peptide_metabolism | 0.60188003 |
| 99 | MP0005365_abnormal_bile_salt | 0.59679528 |
| 100 | MP0001756_abnormal_urination | 0.58804839 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Purpura (HP:0000979) | 9.58048775 |
| 2 | Epistaxis (HP:0000421) | 7.97647723 |
| 3 | Gingival bleeding (HP:0000225) | 6.89418707 |
| 4 | Hyperlipoproteinemia (HP:0010980) | 5.91263753 |
| 5 | Impaired platelet aggregation (HP:0003540) | 5.85863898 |
| 6 | Abnormal platelet function (HP:0011869) | 5.85863898 |
| 7 | Spontaneous hematomas (HP:0007420) | 4.37808357 |
| 8 | Poikilocytosis (HP:0004447) | 4.21481538 |
| 9 | Acanthocytosis (HP:0001927) | 4.20841385 |
| 10 | Dyschromatopsia (HP:0007641) | 4.03184585 |
| 11 | Conjunctival telangiectasia (HP:0000524) | 3.61577386 |
| 12 | Abnormality of the common coagulation pathway (HP:0010990) | 3.50418588 |
| 13 | Bruising susceptibility (HP:0000978) | 3.48572903 |
| 14 | Abnormal pupillary function (HP:0007686) | 3.39631040 |
| 15 | Increased density of long bones (HP:0006392) | 3.18877464 |
| 16 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 3.16125782 |
| 17 | Abnormality of lateral ventricle (HP:0030047) | 3.03840664 |
| 18 | Paralysis (HP:0003470) | 2.94848589 |
| 19 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.86545952 |
| 20 | Xanthomatosis (HP:0000991) | 2.60645313 |
| 21 | Hepatosplenomegaly (HP:0001433) | 2.52120949 |
| 22 | Abnormality of macrophages (HP:0004311) | 2.49958538 |
| 23 | Abnormal auditory evoked potentials (HP:0006958) | 2.45733673 |
| 24 | Joint swelling (HP:0001386) | 2.43922785 |
| 25 | Upper limb muscle weakness (HP:0003484) | 2.42864714 |
| 26 | Increased IgM level (HP:0003496) | 2.40460099 |
| 27 | Joint hemorrhage (HP:0005261) | 2.35725479 |
| 28 | Stomatitis (HP:0010280) | 2.33718047 |
| 29 | Decreased central vision (HP:0007663) | 2.22426132 |
| 30 | Abnormality of iron homeostasis (HP:0011031) | 2.15455618 |
| 31 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.14803142 |
| 32 | Hyperthyroidism (HP:0000836) | 2.11688955 |
| 33 | Tinnitus (HP:0000360) | 2.11172125 |
| 34 | Ventricular fibrillation (HP:0001663) | 2.03381328 |
| 35 | Chronic obstructive pulmonary disease (HP:0006510) | 2.00824930 |
| 36 | Obstructive lung disease (HP:0006536) | 2.00824930 |
| 37 | Prolonged bleeding time (HP:0003010) | 12.1756633 |
| 38 | Menorrhagia (HP:0000132) | 11.3333446 |
| 39 | Increased mean platelet volume (HP:0011877) | 11.3152470 |
| 40 | Abnormal platelet volume (HP:0011876) | 10.6686649 |
| 41 | Petechiae (HP:0000967) | 10.0770722 |
| 42 | Generalized aminoaciduria (HP:0002909) | 1.99167525 |
| 43 | Nausea (HP:0002018) | 1.99051728 |
| 44 | Encephalitis (HP:0002383) | 1.97229577 |
| 45 | Male infertility (HP:0003251) | 1.96262917 |
| 46 | Spontaneous abortion (HP:0005268) | 1.94071982 |
| 47 | 3-Methylglutaconic aciduria (HP:0003535) | 1.91087206 |
| 48 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.88962327 |
| 49 | Arterial thrombosis (HP:0004420) | 1.83876362 |
| 50 | Papillary thyroid carcinoma (HP:0002895) | 1.83121660 |
| 51 | Thyroid-stimulating hormone excess (HP:0002925) | 1.80845886 |
| 52 | Myocardial infarction (HP:0001658) | 1.80701111 |
| 53 | Episodic fever (HP:0001954) | 1.78418126 |
| 54 | Increased serum ferritin (HP:0003281) | 1.77528052 |
| 55 | Dysautonomia (HP:0002459) | 1.74015992 |
| 56 | Polycythemia (HP:0001901) | 1.72303173 |
| 57 | Tongue fasciculations (HP:0001308) | 1.71580309 |
| 58 | Autoimmune hemolytic anemia (HP:0001890) | 1.68072225 |
| 59 | Distal lower limb amyotrophy (HP:0008944) | 1.67889502 |
| 60 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.66019273 |
| 61 | Muscle fibrillation (HP:0010546) | 1.63958926 |
| 62 | Hypophosphatemic rickets (HP:0004912) | 1.61506031 |
| 63 | Eczematoid dermatitis (HP:0000976) | 1.61354202 |
| 64 | Biliary tract neoplasm (HP:0100574) | 1.60015484 |
| 65 | Leiomyosarcoma (HP:0100243) | 1.59761731 |
| 66 | Uterine leiomyosarcoma (HP:0002891) | 1.59761731 |
| 67 | Abnormality of binocular vision (HP:0011514) | 1.57504487 |
| 68 | Diplopia (HP:0000651) | 1.57504487 |
| 69 | Abnormal ciliary motility (HP:0012262) | 1.56316292 |
| 70 | Basal ganglia calcification (HP:0002135) | 1.56286862 |
| 71 | Vertigo (HP:0002321) | 1.55439712 |
| 72 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.53404481 |
| 73 | Abnormality of the prostate (HP:0008775) | 1.51218728 |
| 74 | Polyphagia (HP:0002591) | 1.50147713 |
| 75 | Testicular neoplasm (HP:0010788) | 1.46686155 |
| 76 | Dysostosis multiplex (HP:0000943) | 1.44223343 |
| 77 | Arthropathy (HP:0003040) | 1.42563935 |
| 78 | Chest pain (HP:0100749) | 1.42510036 |
| 79 | Central scotoma (HP:0000603) | 1.41257758 |
| 80 | Infertility (HP:0000789) | 1.40976895 |
| 81 | Bladder neoplasm (HP:0009725) | 1.38760645 |
| 82 | Bladder carcinoma (HP:0002862) | 1.38760645 |
| 83 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.38101582 |
| 84 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.37863403 |
| 85 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.37191866 |
| 86 | Abnormality of alanine metabolism (HP:0010916) | 1.37191866 |
| 87 | Hyperalaninemia (HP:0003348) | 1.37191866 |
| 88 | Lower limb amyotrophy (HP:0007210) | 1.34578540 |
| 89 | Thrombocytosis (HP:0001894) | 1.33341029 |
| 90 | Mucosal telangiectasiae (HP:0100579) | 1.31804158 |
| 91 | Thrombophlebitis (HP:0004418) | 1.31093875 |
| 92 | Mitral stenosis (HP:0001718) | 1.30596688 |
| 93 | Cerebral ischemia (HP:0002637) | 1.29711732 |
| 94 | Leukocytosis (HP:0001974) | 1.28439962 |
| 95 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.26060698 |
| 96 | Abnormality of the Achilles tendon (HP:0005109) | 1.25069365 |
| 97 | Cerebral hemorrhage (HP:0001342) | 1.24315477 |
| 98 | Hypertriglyceridemia (HP:0002155) | 1.24121876 |
| 99 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.23149128 |
| 100 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.23149128 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 5.54366150 |
| 2 | MST4 | 5.03238858 |
| 3 | BMX | 4.40763460 |
| 4 | MYLK | 3.85272599 |
| 5 | EIF2AK1 | 3.63756624 |
| 6 | TEC | 3.28331326 |
| 7 | BTK | 2.86595493 |
| 8 | PTK2B | 2.65634762 |
| 9 | SYK | 2.23086331 |
| 10 | CSF1R | 2.17483232 |
| 11 | GRK5 | 2.14882597 |
| 12 | PIK3CG | 2.14637391 |
| 13 | ILK | 2.05726294 |
| 14 | TAOK3 | 2.01435868 |
| 15 | GRK6 | 1.94421500 |
| 16 | BMPR2 | 1.92371599 |
| 17 | ZAP70 | 1.91018273 |
| 18 | FGR | 1.76874874 |
| 19 | STK3 | 1.59483737 |
| 20 | ADRBK2 | 1.49853110 |
| 21 | HCK | 1.46483310 |
| 22 | BLK | 1.32647126 |
| 23 | MAPKAPK3 | 1.31378868 |
| 24 | PAK1 | 1.23342436 |
| 25 | PIM2 | 1.21980850 |
| 26 | FES | 1.21917357 |
| 27 | MAP2K3 | 1.20410219 |
| 28 | TNK2 | 1.18992801 |
| 29 | LMTK2 | 1.16743224 |
| 30 | STK24 | 1.14797101 |
| 31 | PLK2 | 1.13234965 |
| 32 | ACVR1B | 1.12233983 |
| 33 | DAPK3 | 1.10382582 |
| 34 | LYN | 1.10171761 |
| 35 | IKBKB | 1.05968506 |
| 36 | TNIK | 1.00622398 |
| 37 | SIK3 | 0.95493552 |
| 38 | IRAK1 | 0.91791120 |
| 39 | MATK | 0.89459992 |
| 40 | ITK | 0.88715833 |
| 41 | PNCK | 0.88401158 |
| 42 | ARAF | 0.87762681 |
| 43 | MAP3K5 | 0.86615621 |
| 44 | ADRBK1 | 0.86165673 |
| 45 | TRIM28 | 0.85780851 |
| 46 | EPHA3 | 0.85151580 |
| 47 | MARK3 | 0.84311764 |
| 48 | CSK | 0.82171588 |
| 49 | TXK | 0.81017589 |
| 50 | TAOK2 | 0.80208551 |
| 51 | PDK1 | 0.74971648 |
| 52 | RET | 0.70852654 |
| 53 | TAOK1 | 0.69688592 |
| 54 | PRKD1 | 0.69324923 |
| 55 | ERBB2 | 0.68275168 |
| 56 | PKN1 | 0.67262375 |
| 57 | IRAK4 | 0.65077433 |
| 58 | DAPK2 | 0.63065980 |
| 59 | EPHB2 | 0.62994909 |
| 60 | PDPK1 | 0.62757001 |
| 61 | MAP3K3 | 0.60349161 |
| 62 | FER | 0.58261844 |
| 63 | PDGFRB | 0.56952936 |
| 64 | PRKACG | 0.53275683 |
| 65 | STK4 | 0.50550681 |
| 66 | MAPK12 | 0.50485345 |
| 67 | MAP2K1 | 0.49676699 |
| 68 | MAP3K12 | 0.49340452 |
| 69 | TESK2 | 0.49273347 |
| 70 | TLK1 | 0.49145247 |
| 71 | BMPR1B | 0.46357765 |
| 72 | LCK | 0.46013224 |
| 73 | FYN | 0.45512533 |
| 74 | MINK1 | 0.45464542 |
| 75 | MAP3K11 | 0.45073572 |
| 76 | EPHB1 | 0.41845057 |
| 77 | YES1 | 0.41295754 |
| 78 | PRKG1 | 0.39957712 |
| 79 | JAK2 | 0.39649861 |
| 80 | IRAK2 | 0.38874143 |
| 81 | JAK3 | 0.38337215 |
| 82 | DAPK1 | 0.36910414 |
| 83 | JAK1 | 0.35969156 |
| 84 | CAMKK2 | 0.35817994 |
| 85 | SGK2 | 0.35161766 |
| 86 | MAPK13 | 0.34373757 |
| 87 | PRKCD | 0.33900339 |
| 88 | PAK3 | 0.32983284 |
| 89 | GRK1 | 0.31614037 |
| 90 | PIM1 | 0.30113050 |
| 91 | PRKCB | 0.29509503 |
| 92 | IRAK3 | 0.28648729 |
| 93 | PRKCQ | 0.28121235 |
| 94 | ROCK1 | 0.26924102 |
| 95 | SRC | 0.26685031 |
| 96 | NUAK1 | 0.26277533 |
| 97 | PRKCA | 0.25689871 |
| 98 | SGK3 | 0.24474556 |
| 99 | NLK | 0.23823971 |
| 100 | MAP4K1 | 0.23349307 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Platelet activation_Homo sapiens_hsa04611 | 5.68734921 |
| 2 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 3.70926854 |
| 3 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 2.98435525 |
| 4 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.53390784 |
| 5 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 2.52794330 |
| 6 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.46665168 |
| 7 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 2.08846129 |
| 8 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.92610824 |
| 9 | Gap junction_Homo sapiens_hsa04540 | 1.90380544 |
| 10 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.67847566 |
| 11 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.66098868 |
| 12 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.63546063 |
| 13 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.63247820 |
| 14 | Alcoholism_Homo sapiens_hsa05034 | 1.41151747 |
| 15 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.38680322 |
| 16 | Endocytosis_Homo sapiens_hsa04144 | 1.36030681 |
| 17 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.35144081 |
| 18 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.32016095 |
| 19 | Shigellosis_Homo sapiens_hsa05131 | 1.30697371 |
| 20 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.28558608 |
| 21 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.23070156 |
| 22 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.21671301 |
| 23 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.20670482 |
| 24 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.20107674 |
| 25 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.14864581 |
| 26 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.11706065 |
| 27 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.11486397 |
| 28 | Long-term depression_Homo sapiens_hsa04730 | 1.09080001 |
| 29 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.05919025 |
| 30 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.04367962 |
| 31 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.03887024 |
| 32 | Malaria_Homo sapiens_hsa05144 | 1.00876191 |
| 33 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.00002217 |
| 34 | Phagosome_Homo sapiens_hsa04145 | 0.99017456 |
| 35 | Olfactory transduction_Homo sapiens_hsa04740 | 0.96139254 |
| 36 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.94100454 |
| 37 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.93692857 |
| 38 | Focal adhesion_Homo sapiens_hsa04510 | 0.92091880 |
| 39 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.88663364 |
| 40 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.88420226 |
| 41 | Circadian entrainment_Homo sapiens_hsa04713 | 0.86700260 |
| 42 | Morphine addiction_Homo sapiens_hsa05032 | 0.85761561 |
| 43 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.83853153 |
| 44 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.79692192 |
| 45 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.77558501 |
| 46 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.77378211 |
| 47 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.76373477 |
| 48 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.75125858 |
| 49 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.74268821 |
| 50 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.70677295 |
| 51 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.68218894 |
| 52 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.64988796 |
| 53 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.64380824 |
| 54 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.64242161 |
| 55 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.62321393 |
| 56 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.62096896 |
| 57 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.59537844 |
| 58 | Endometrial cancer_Homo sapiens_hsa05213 | 0.59524457 |
| 59 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.59237172 |
| 60 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.58429851 |
| 61 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.58406924 |
| 62 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.58313981 |
| 63 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.58229038 |
| 64 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.57984528 |
| 65 | Amoebiasis_Homo sapiens_hsa05146 | 0.57200702 |
| 66 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.57188300 |
| 67 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.56386271 |
| 68 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.56196772 |
| 69 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.56189780 |
| 70 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.55049171 |
| 71 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.53372654 |
| 72 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.53208518 |
| 73 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.52781640 |
| 74 | GABAergic synapse_Homo sapiens_hsa04727 | 0.52218775 |
| 75 | Salmonella infection_Homo sapiens_hsa05132 | 0.51548560 |
| 76 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.51307477 |
| 77 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.50769341 |
| 78 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.48998974 |
| 79 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.48961662 |
| 80 | Glioma_Homo sapiens_hsa05214 | 0.48336008 |
| 81 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.46919201 |
| 82 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.46791113 |
| 83 | Melanoma_Homo sapiens_hsa05218 | 0.46349289 |
| 84 | Mismatch repair_Homo sapiens_hsa03430 | 0.46060735 |
| 85 | Renin secretion_Homo sapiens_hsa04924 | 0.45488256 |
| 86 | Asthma_Homo sapiens_hsa05310 | 0.44678687 |
| 87 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.44657533 |
| 88 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.43951522 |
| 89 | Phototransduction_Homo sapiens_hsa04744 | 0.43539613 |
| 90 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.42719317 |
| 91 | Apoptosis_Homo sapiens_hsa04210 | 0.42656686 |
| 92 | Leishmaniasis_Homo sapiens_hsa05140 | 0.41275548 |
| 93 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.41203775 |
| 94 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.40024635 |
| 95 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.39502873 |
| 96 | Allograft rejection_Homo sapiens_hsa05330 | 0.38886075 |
| 97 | Legionellosis_Homo sapiens_hsa05134 | 0.38223384 |
| 98 | Tuberculosis_Homo sapiens_hsa05152 | 0.37570837 |
| 99 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.37244017 |
| 100 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.36517753 |

